Semyon Faynboym, MD
Pain Medicine · Torrance
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 15
- 3 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Faynboym’s office at (323) 638-4263 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A138237 · Current
Licensed to practise in California · since 2015 · expires 2027-08-31 · St. George'S University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$16,117 in 2018
Medicaid paid $16,117 for 1,225 billed services this clinician did in 2018, up to 66 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 433 | $7,545 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 243 | $4,426 |
| Short return visit (20+ min) | 360 | $3,777 |
| Injection, methylprednisolone acetate, 40 mg | 140 | $164 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 21 | $160 |
| URINE PREGNANCY TEST | 28 | $47 |
| 2018 | 1,225 | 6 | 66 | $16,117 |
Drugs they prescribed that Part D paid
$292
Pharmacies billed $292 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 49) in 2024. Too few prescriptions to compare fairly with other clinicians.
49 generic and 0 brand-name prescriptions · $292 in drug cost · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Risperidone | 13 | $68 | $5 |
| Lithium Carbonate | 12 | $43 | $4 |
Year by year
| 2024 | 49 | None | 0% (0) | 0% | $292 |
| 2023 | 51 | None | 0% (0) | 0% | $317 |
| 2022 | 58 | None | 0% (0) | None | $1,500 |
| 2021 | 28 | None | 0% (0) | 0% | $402 |
| 2020 | 25 | None | 0% (0) | 0% | $187 |
| 2019 | 229 | 95 | 33% (75) | 5% | $8,286 |
| 2018 | 1,796 | 175 | 46% (825) | 31% | $275,248 |
| 2017 | 2,754 | 226 | 47% (1,285) | 33% | $758,024 |
| 2016 | 703 | 128 | 38% (264) | 31% | $76,992 |
| 2015 | 359 | 49 | 0% (0) | 8% | $32,513 |
| 2014 | 181 | 34 | 0% (0) | 8% | $13,648 |
| 2013 | 97 | 12 | None | 32% | $10,525 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Risperidone | 11 | $66 | $6 |
| Lithium Carbonate | 11 | $36 | $3 |
2019: 3 drugs
| Hydrocodone-Acetaminophen | 46 | $866 | $19 |
| Gabapentin | 72 | $851 | $12 |
| Tizanidine | 14 | $131 | $9 |
2018: 35 drugs
| Evzio | 20 | $83,124 | $4,156 |
| Belbuca | 135 | $40,656 | $301 |
| Lyrica | 79 | $28,381 | $359 |
| Nucynta Er | 75 | $23,710 | $316 |
| Nucynta | 66 | $16,853 | $255 |
| Xtampza Er | 56 | $12,820 | $229 |
| Butrans | 22 | $11,044 | $502 |
| Hydromorphone Er | 12 | $7,444 | $620 |
| Oxycodone-Acetaminophen | 165 | $6,089 | $37 |
| Gabapentin | 213 | $3,920 | $18 |
| Diclofenac | 89 | $3,139 | $35 |
| Hydrocodone-Acetaminophen | 139 | $3,062 | $22 |
| Narcan | 15 | $1,899 | $127 |
| Voltaren | 12 | $1,531 | $128 |
| Tramadol Hcl Er | 23 | $1,513 | $66 |
| Suboxone | 11 | $1,296 | $118 |
| Tizanidine | 21 | $674 | $32 |
| Methylprednisolone | 34 | $444 | $13 |
| Cyclobenzaprine | 49 | $391 | $8 |
| Testosterone Cypionate | 14 | $372 | $27 |
| Meloxicam | 39 | $368 | $9 |
| Tramadol | 65 | $348 | $5 |
| Bupropion Xl | 18 | $321 | $18 |
| Acetaminophen-Codeine | 22 | $281 | $13 |
| Celecoxib | 16 | $261 | $16 |
| Lamotrigine | 23 | $225 | $10 |
| Quetiapine | 18 | $222 | $12 |
| Topiramate | 33 | $211 | $6 |
| Hydroxyzine | 11 | $209 | $19 |
| Clonidine | 30 | $141 | $5 |
| Ondansetron Odt | 13 | $135 | $10 |
| Trazodone | 28 | $122 | $4 |
| Buspirone | 20 | $114 | $6 |
| Ketorolac Tromethamine | 11 | $95 | $9 |
| Ranitidine | 11 | $51 | $5 |
2017: 42 drugs
| Evzio | 54 | $447,805 | $8,293 |
| Lyrica | 187 | $59,303 | $317 |
| Nucynta Er | 175 | $49,860 | $285 |
| Hysingla Er | 88 | $37,277 | $424 |
| Butrans | 87 | $34,102 | $392 |
| Belbuca | 99 | $23,733 | $240 |
| Hydromorphone Er | 13 | $11,724 | $902 |
| Oxycodone-Acetaminophen | 246 | $9,991 | $41 |
| Xtampza Er | 44 | $7,951 | $181 |
| Nucynta | 40 | $7,856 | $196 |
| Embeda | 16 | $7,173 | $448 |
| Oxycontin | 15 | $6,110 | $407 |
| Movantik | 16 | $5,049 | $316 |
| Gabapentin | 349 | $4,971 | $14 |
| Voltaren | 27 | $3,457 | $128 |
| Hydrocodone-Acetaminophen | 205 | $3,210 | $16 |
| Diclofenac | 68 | $2,792 | $41 |
| Tramadol Hcl Er | 44 | $2,041 | $46 |
| Celecoxib | 21 | $1,824 | $87 |
| Fentanyl | 12 | $1,584 | $132 |
| Lidocaine | 13 | $1,141 | $88 |
| Oxycodone | 31 | $1,033 | $33 |
| Bupropion Xl | 37 | $879 | $24 |
| Morphine Sulfate Er | 26 | $756 | $29 |
| Diclofenac | 11 | $660 | $60 |
| Tramadol | 107 | $594 | $6 |
| Cyclobenzaprine | 28 | $459 | $16 |
| Tizanidine | 14 | $457 | $33 |
| Chlorzoxazone | 27 | $443 | $16 |
| Hydroxyzine | 29 | $399 | $14 |
| Clonidine | 75 | $395 | $5 |
| Methylprednisolone | 28 | $373 | $13 |
| Hydroxyzine Pamoate | 32 | $373 | $12 |
| Duloxetine | 19 | $368 | $19 |
| Trazodone | 74 | $337 | $5 |
| Meloxicam | 67 | $231 | $3 |
| Topiramate | 41 | $207 | $5 |
| Baclofen | 20 | $175 | $9 |
| Quetiapine | 19 | $174 | $9 |
| Lamotrigine | 17 | $116 | $7 |
| Ondansetron Odt | 16 | $61 | $4 |
| Buspirone | 14 | $59 | $4 |
2016: 16 drugs
| Butrans | 47 | $14,148 | $301 |
| Hysingla Er | 28 | $10,474 | $374 |
| Lyrica | 31 | $8,366 | $270 |
| Nucynta Er | 26 | $7,844 | $302 |
| Voltaren | 41 | $4,739 | $116 |
| Diclofenac | 31 | $2,653 | $86 |
| Hydrocodone-Acetaminophen | 80 | $2,438 | $30 |
| Oxycodone-Acetaminophen | 45 | $1,871 | $42 |
| Gabapentin | 82 | $902 | $11 |
| Duloxetine | 13 | $815 | $63 |
| Oxycodone | 16 | $466 | $29 |
| Bupropion Xl | 16 | $347 | $22 |
| Tramadol | 19 | $346 | $18 |
| Clonidine | 20 | $114 | $6 |
| Hydroxyzine Pamoate | 13 | $114 | $9 |
| Trazodone | 14 | $52 | $4 |
2015: 15 drugs
| Abilify | 20 | $18,751 | $938 |
| Divalproex Sodium Er | 19 | $2,515 | $132 |
| Quetiapine | 18 | $874 | $49 |
| Bupropion Xl | 24 | $716 | $30 |
| Gabapentin | 18 | $517 | $29 |
| Amitriptyline | 19 | $369 | $19 |
| Escitalopram | 22 | $230 | $10 |
| Mirtazapine | 13 | $229 | $18 |
| Venlafaxine Hcl Er | 17 | $218 | $13 |
| Fluoxetine | 18 | $176 | $10 |
| Citalopram Hbr | 19 | $112 | $6 |
| Alprazolam | 17 | $107 | $6 |
| Trazodone | 19 | $92 | $5 |
| Paroxetine | 11 | $77 | $7 |
| Clonazepam | 12 | $30 | $2 |
2014: 5 drugs
| Divalproex Sodium Er | 12 | $1,623 | $135 |
| Quetiapine | 13 | $1,604 | $123 |
| Bupropion Xl | 17 | $729 | $43 |
| Escitalopram | 11 | $197 | $18 |
| Alprazolam | 11 | $97 | $9 |
2013: 1 drug
| Metoprolol | 11 | $377 | $34 |
Money from drug and device companies
$12,150 in 2025
| 2025 | 11 | 52 | $9,900 | $12,150 |
| 2024 | 6 | 35 | None | $713 |
| 2023 | 4 | 16 | None | $479 |
| 2022 | 5 | 9 | None | $367 |
| 2021 | 4 | 15 | None | $341 |
| 2019 | 2 | 3 | None | $537 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $11,650 | 30 payments
|
| Abbvie | Vraylar | $210 | 11 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $56 | 2 payments
|
| Bausch Health US | Aplenzin | $47 | 2 payments
|
| Janssen Pharmaceuticals | Spravato | $33 | 1 payment
|
| Lundbeck | Rexulti | $32 | 1 payment
|
See all 52 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-24 | Caplyta | $1,800 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-23 | Caplyta | $1,800 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-19 | Caplyta | $1,800 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Consulting · 2025-12-18 | Caplyta | $2,880 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-11 | Caplyta | $125 |
| Bausch Health US | Meals · 2025-12-09 | Aplenzin | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-09 | Caplyta | $129 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-21 | Caplyta | $22 |
| Collegium Pharmaceutical | Meals · 2025-11-17 | Jornay Pm | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-13 | Caplyta | $115 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-03 | Caplyta | $23 |
| Abbvie | Meals · 2025-10-28 | Vraylar | $9 |
| Janssen Pharmaceuticals | Meals · 2025-10-21 | Spravato | $33 |
| Axsome Therapeutics | Meals · 2025-10-14 | Auvelity | $31 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-10-11 | Caplyta | $418 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-10-11 | Caplyta | $66 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-10-11 | Caplyta | $118 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-10-11 | Caplyta | $307 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-11 | Caplyta | $34 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-11 | Caplyta | $34 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-11 | Caplyta | $57 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-11 | Caplyta | $49 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-11 | Caplyta | $35 |
| Abbvie | Meals · 2025-10-10 | Vraylar | $8 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-08 | Caplyta | $15 |
| Abbvie | Meals · 2025-09-17 | Vraylar | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-04 | Caplyta | $33 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-17 | Caplyta | $3 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-17 | Caplyta | $16 |
| Abbvie | Meals · 2025-08-01 | Vraylar | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-01 | Caplyta | $31 |
| Noven Therapeutics | Meals · 2025-07-25 | Xelstrym | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-23 | Trintellix | $29 |
| Abbvie | Meals · 2025-07-17 | Vraylar | $26 |
| Lundbeck | Meals · 2025-07-10 | Rexulti | $32 |
| Abbvie | Meals · 2025-07-09 | Vraylar | $8 |
| Abbvie | Meals · 2025-07-08 | Vraylar | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-25 | Caplyta | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Consulting · 2025-06-20 | Caplyta | $1,620 |
| Otsuka America Pharmaceutical | Meals · 2025-06-09 | Rexulti | $15 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-19 | Caplyta | $5 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-17 | Caplyta | $5 |
| Abbvie | Meals · 2025-05-07 | Vraylar | $23 |
| Bausch Health US | Meals · 2025-05-05 | Aplenzin | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-01 | Caplyta | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-24 | Caplyta | $31 |
| Abbvie | Meals · 2025-04-16 | Vraylar | $23 |
| Abbvie | Meals · 2025-03-26 | Vraylar | $29 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-26 | Caplyta | $28 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-19 | Trintellix | $27 |
| Abbvie | Meals · 2025-01-15 | Vraylar | $27 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-01-08 | Rejoyn | $29 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $713
| Abbvie | Vraylar | $365 | 20 payments
|
| Bausch Health US | Aplenzin | $90 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $71 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $65 | 3 payments
|
| Axsome Therapeutics | Auvelity | $62 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $60 | 3 payments
|
2023: $479
| Axsome Therapeutics | Auvelity | $230 | 5 payments
|
| Abbvie | Vraylar | $141 | 7 payments
|
| Biogen | None | $70 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $38 | 2 payments
|
2022: $367
| Janssen Pharmaceuticals | Spravato | $154 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Mycite | $90 | 4 payments
|
| Abbvie | Vraylar | $53 | 2 payments
|
| Harmony Biosciences | Wakix | $45 | 1 payment
|
| Bausch Health US | Aplenzin | $25 | 1 payment
|
2021: $341
| Bausch Health US | Aplenzin | $151 | 9 payments
|
| AbbVie | Vraylar | $101 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Mycite | $71 | 3 payments
|
| Janssen Pharmaceuticals | Spravato | $18 | 1 payment
|
2019: $537
| Abbott Laboratories | Axium Ins Drg Ipg | $509 | 2 payments
|
| Stryker | Ivs - Vertebral Augmentation Products | $28 | 1 payment
|
Professional record
- NPI
- 1215295548
- Licence
- CA 138237, IN 01076211ACalifornia A138237: Current · expires 2027-08-31
More record details
- Sole proprietor
- No
- Medicaid ID
- IN 201099940
- Taxonomy
- Federal specialty code 2084P2900X (2084P2900X); Federal specialty code 208100000X (208100000X); Psychiatry (2084P0800X)
- Mailing address
- 3701 Santa Rosalia Dr Ste 1093, Los Angeles, CA, 90008
- NPI first listed
- 2012-04-24
- NPI last updated
- 2026-09-16
- NPI record certified
- 2026-09-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3425 S Bascom Ave Ste 200, Campbell, CA, 95008 · 3600 Lomita Blvd Ste 200, Torrance, CA, 90505